Drug Profile
Research programme: pain therapeutics - BetterLife Pharma
Alternative Names: NK-003Latest Information Update: 13 Dec 2019
Price :
$50
*
At a glance
- Originator Neurokine Pharmaceuticals
- Class
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Intervertebral disc displacement; Sciatica
Most Recent Events
- 05 Dec 2019 Pivot Pharmaceuticals is now called BetterLife Pharma
- 16 Jul 2016 No recent reports of development identified for research development in Intervertebral-disc-displacement in Canada
- 16 Jul 2016 No recent reports of development identified for research development in Sciatica in Canada